Search

everythinglearnresearchcommunity

for

Search:↓

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Nutrafol might help reduce hair loss due to inflammation, but more evidence is needed.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

The document concludes that stem cell inactivity is actively controlled and important for tissue repair and balance.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Researchers created a mouse with the same mutation as humans with trichothiodystrophy, showing similar symptoms and confirming the condition is due to defects in DNA repair and gene activity.

Genomic approach finds new possible treatments for hair loss.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

The Hairless gene is crucial for healthy skin and hair growth.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Human keratinocytes do not naturally respond to androgens.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Skin pigmentation varies due to genetics, UV exposure, and medications, with treatments available but requiring medical advice.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.